Depicting this favored hydrogen bond pair as well as the reported key role in hACE2/SARS-CoV-2 spike-protein association introduces the promising action of alacepril to counter COVID-19/host entrance and subsequent release of viral payload RNA into the host cytoplasm through hampering hACE2 spike-protein annealing and anchoring. The gene discussed is CHMP5; the disease is COVID-19.